148
352– 372): naturally occurring amino acid variant Gly364Ser causes profound changes in
human autonomic activity and alters risk for hypertension. Circulation 115:2271–2281
Reinecke M, Höög A, Ostenson CG, Efendic S, Grimelius L, Falkmer S (1991) Phylogenetic
aspects of pancreastatin- and chromogranin-like immunoreactive cells in the gastro-entero-
pancreatic neuroendocrine system of vertebrates. Gen Comp Endocrinol 83:167–182
Seternes T, Oynebraten I, Sorensen K, Smedsrod B (2001) Specific endocytosis and catabolism in
the scavenger endothelial cells of cod (Gadus morhua L.) generate high-energy metabolites.
J Exp Biol 204:1537–1546
Shiels HA, White E (2008) The Frank–Starling mechanism in vertebrate cardiac myocytes. J Exp
Biol 211:2005–2011
Smart D, Johnston CF, Curry WJ, Shaw C, Halton DW, Fairweather I, Buchanan KD (1992)
Immunoreactivity to two specific regions of chromogranin A in the nervous system of Ascaris
suum: an immunocytochemical study. Parasitol Res 78:329–335
Steiner HJ, Weiler R, Ludescher C, Schmid KW, Winkler H (1990) Chromogranins A and B are
co-localized with atrial natriuretic peptides in secretory granules of rat heart. J Histochem
Cytochem 38:845–850
Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M, Van Dorsselaer A, Aunis D,
Metz-Boutigue MH (1996) Antibacterial activity of glycosylated and phosphorylated chromo-
granin A-derived peptide 173–194 from bovine adrenal medullary chromaffin granules. J Biol
Chem 271:28533–28540
Sys SU, Pellegrino D, Mazza R, Gattuso A, Andries LJ, Tota B (1997) Endocardial endothelium in
the avascular heart of the frog: morphology and role of nitric oxide. J Exp Biol 200:3109–3118
Tatemoto K, Efendić S, Mutt V, Makk G, Feistner GJ, Barchas JD (1986) Pancreastatin, a novel
pancreatic peptide that inhibits insulin secretion. Nature 324:476–478
Tota B, Mazza R, Angelone T, Nullans G, Metz-Boutigue MH, Aunis D, Helle KB (2003) Peptides
from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in
the isolated frog heart. Regul Pept 114:91–99
Tota B, Imbrogno S, Mannarino C, Mazza R (2004) Vasostatins and negative inotropy in vertebrate
hearts. Curr Med Chem Immun Endoc Metab Agents 4:195–201
Tota B, Quintieri AM, Di Felice V, Cerra MC (2007) New biological aspects of chromogranin
A-derived peptides: focus on vasostatins. Comp Biochem Physiol A Physiol 147:11–18
Trandaburu T, Ali SS, Trandaburu I (1999) Granin proteins (chromogranin A and secretogranin II
C23–3 and C26–3) in the intestine of reptiles. Ann Anat 81:261–268
Vesely DL (2006) Which of the cardiac natriuretic peptides is most effective for the treatment of
congestive heart failure, renal failure and cancer? Clin Exp Pharmacol Physiol 33:169–176
Vesely DL, Douglass MA, Dietz JR, Gower WR Jr, McCormick MT, Rodriguez-Paz G, Schocken DD
(1994) Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood
pressure and produce diuresis, natriuresis, and/or kaliuresis in humans. Circulation 90:1129–1140
Weiergraber M, Pereverzev A, Vajna R, Henry M, Schramm M, Nastainczyk W, Grabsch H,
Schneider T (2000) Immunodetection of alpha1E voltagegated Ca(2+) channel in chromogranin-
positive muscle cells of rat heart, and in distal tubules of human kidney. J Histochem Cytochem
48:807–819
Wen G, Mahata SK, Cadman P, Mahata M, Ghosh S, Mahapatra NR, Rao F, Stridsberg M, Smith
DW, Mahboubi P, Schork NJ, O’Connor DT, Hamilton BA (2004) Both rare and common poly-
morphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.
Am J Hum Genet 74:197–207
A. Gattuso et al.